Navigation Links
New Eye Treatment May Save Preemies' Sight
Date:2/17/2011

By Randy Dotinga
HealthDay Reporter

WEDNESDAY, Feb. 16 (HealthDay News) -- A new study holds potentially good news for preterm infants who develop an eye condition that may cause blindness: An inexpensive drug appears to do a better job of treating the condition than the existing therapy.

Just 4 percent of babies treated with the cancer drug Avastin suffered a recurrence of retinopathy of prematurity, a disease that harms the retina. By contrast, it recurred in 22 percent of those who received laser treatment to combat the condition, which is the most common cause of blindness in infants.

The treatment, given by injection in the eye, costs $40 for both eyes and doesn't need an eye doctor on hand, making it a good option for poor countries where the disease is more common, said study author Dr. Helen A. Mintz-Hittner, a pediatric ophthalmologist at the University of Texas Health Science Center at Houston.

"You're paying $40 for a pair of eyes for 80 years," Mintz-Hittner said, referring to the lifespan of patients who may avoid blindness. "You can't get much more bang for your buck than that. It's really a major advance."

Retinopathy of prematurity most commonly occurs in babies born extremely prematurely who receive oxygen treatment after birth. In some cases, babies get too much oxygen and the lungs fail to deliver it properly to the body, depriving tissues in the developing eye, explained Dr. James D. Reynolds, chair of the department of ophthalmology at the University at Buffalo, who wrote a commentary accompanying the study.

"We try the best we can to duplicate the in-utero conditions, but obviously we cannot," he said. As the baby grows after birth, the developing eye can be damaged as blood vessels grow abnormally; the retinas detach in some of the infants months after birth and may result in blindness.

Laser treatment can stop the progress toward blindness, but it also may cause infants to lose peripheral vision and suffer from poor overall vision, Mintz-Hittner said. As adults, "they're not able to see off to the side, they have very thick glasses, and it's hard for them to drive," she said.

The study is published in the Feb. 17 issue of the New England Journal of Medicine.

Avastin (bevacizumab), is best known as a chemotherapy drug, but it's also used to treat eye disease. The researchers tested either the drug or laser therapy on 143 infants and found that it worked well on babies with one type of the disease.

The drug works by blocking the abnormal growth of blood vessels, Reynolds said. "We are going to save some babies who would have gone blind with the laser treatment," Reynolds said. "It will change the patterns of practice overnight."

Timing of the injections is critical to the drug's success, the authors noted, and more research is necessary to determine the appropriate dose for different forms of the disease.

The U.S. Food and Drug Administration recently announced a plan to rescind its conditional approval of Avastin for treating breast cancer after serious side effects were noted in some patients and recent studies failed to show survival benefit.

Addressing safety concerns, the authors of this study said no ill effects were seen and that the dose used in the eye is only a fraction of that needed for cancer treatment.

However, because of the small size of their study, they recommend ongoing monitoring of children injected with Avastin to watch for any systemic effects.

The study was funded by the Research to Prevent Blindness, the U.S. National Eye Institute and other non-industry sources.

More information

For more about retinopathy of prematurity, see the U.S. National Library of Medicine.

SOURCES: Helen A. Mintz-Hittner, pediatric ophthalmologist, University of Texas Health Science Center at Houston; James D. Reynolds, M.D., chair, Department of Ophthalmology, University at Buffalo. Feb. 17, 2011, The New England Journal of Medicine


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Despite Treatment, Employees with Depression Generate Higher Absentee Costs, According to Thomson Reuters Study
2. Women More Likely to Fail Treatment for Atrial Fibrillation
3. Social Anxiety and Panic - Alternative Treatment to Drugs and Therapy
4. Neuroimaging study may pave way for effective Alzheimers treatments
5. Nanofilm Introduces Clarity Defog It™ Anti Fog Treatment and EcoClens™ Eco-Friendly Lens Cleaner at Vision Expo East
6. Many veterans not getting enough treatment for PTSD
7. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
8. Allegheny General Hospital Study Demonstrates Safety and Potential Efficacy of Oral Allergy Treatment
9. Charging less for more effective treatments could reduce health care costs while improving health
10. Added Drug Aids MS Treatment
11. PTSD Treatment Still Lacking for Veterans
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Eye Treatment May Save Preemies' Sight
(Date:10/13/2017)... ... October 13, 2017 , ... As health professionals work to improve their ... The patient is doing more than filling out a survey; in many cases health ... increasing emphasis in health care and research on the importance of active engagement with ...
(Date:10/13/2017)... , ... October 13, 2017 ... ... of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ... on guideline updates for the primary prevention of cardiovascular diseases during the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network for professional ... action towards gender equality at their inaugural Summit in New York City in June. ... a social audience of over 3 million. To watch the Mobilize Women video, ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
(Date:9/19/2017)... , Sept. 19, 2017   ZirMed Inc ., a ... today announced that it has been ranked #1 by its ... Book™ Rankings 2017 User Survey. ZirMed was recognized as ... large hospitals and medical centers over 200 beds and holds ... healthcare technology user survey history. ...
(Date:9/12/2017)... LAKES, N.J. , Sept. 12, 2017  Consumer reviews on ... Embrace Hearing as the number one company for hearing aids, ... ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides ...
Breaking Medicine Technology: